TILT Holdings Reports Results of 2024 Annual General Meeting of Shareholders
June 12, 2024 16:30 ET
|
TILT Holdings Inc.
PHOENIX, June 12, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQB: TLLTF), a global provider of cannabis business solutions that include inhalation...
Investment Opportunity: PlantForm Corporation Seeks $25M to Accelerate Plant-Based Medical Breakthroughs
June 12, 2024 14:40 ET
|
US Capital Global
San Francisco, California, USA, June 12, 2024 (GLOBE NEWSWIRE) -- US Capital Global Securities LLC, an SEC-registered affiliate of renowned global financial group US Capital Global, is pleased to...
Metrc Announces First-Ever Track-And-Trace Contract with a Tribal Government, in Partnership with the Twenty-Nine Palms Band of Mission Indians
June 12, 2024 08:30 ET
|
Metrc LLC
LAKELAND, Fla., June 12, 2024 (GLOBE NEWSWIRE) -- Metrc, the most trusted and experienced provider of cannabis regulatory technology systems in the U.S., announced a new contract with the...
Monaghan Medical Corporation and Captis Continue to Partner to Improve Patient Outcomes
June 11, 2024 09:00 ET
|
Monaghan Medical Corporation
Monaghan & Captis announce a 2nd, 3-year contract. The agreement highlights the value of Monaghan, and Captis’ commitment to driving process efficiencies.
Levita Magnetics Selects RTI Connext as the Connectivity Solution for its MARS Surgical Robotic System
June 11, 2024 08:00 ET
|
Real-Time Innovations (RTI)
Levita Magnetics selects RTI Connext as the connectivity solution for its MARS Surgical Robotic System.
DaySavers and the Cannabis Research Coalition Want to Pay You to Smoke Joints for Science
June 10, 2024 10:00 ET
|
Custom Cones USA
DaySavers and the Cannabis Research Coalition Want to Pay You to Smoke Joints for Science
Assembly Biosciences Doses First Participant in Phase 1a/b Clinical Trial of Herpes Simplex Virus Helicase-Primase Inhibitor Candidate ABI-5366
June 10, 2024 08:00 ET
|
Assembly Biosciences, Inc.
– Phase 1a study portion of single ascending dosing in healthy participants will inform the development of ABI-5366 with interim data expected in Q3 2024 – – Phase 1b study portion of multiple...
Retrieve Medical Announces Newly Issued Patent for Enhanced Problem List Management in EHR Systems
June 06, 2024 08:30 ET
|
Retrieve Medical, Inc.
Retrieve Medical Announces Newly Issued Patent for Enhanced Problem List Management in EHR Systems
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
June 05, 2024 08:00 ET
|
Assembly Biosciences, Inc.
-- Poster highlights promising preclinical profile of ABI-6250 ahead of entry into the clinic, expected by end of 2024 -- SOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Assembly...
Retrieve Medical, Inc. Selected to Exhibit Retrieve Dx(TM) at Vizient Innovative Technology Exchange
June 04, 2024 11:00 ET
|
Retrieve Medical, Inc.
Retrieve Medical, Inc. Selected to Exhibit Retrieve DxTM at Vizient Innovative Technology Exchange